PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
The PI3K pathway is frequently hyperactivated in primary T-cell acute lymphoblastic leukemia (T-ALL) cells. Activation of the PI3K pathway has been suggested as one mechanism of glucocorticoid resistance in T-ALL, and patients harboring mutations in the PI3K negative regulator PTEN may be at increas...
Main Authors: | Silveira, André Bortolini, Laranjeira, Angelo Brunelli Albertoni, Rodrigues, Gisele Olinto Libanio, Leal, Paulo César, Cardoso, Bruno António, Barata, João Taborda, Yunes, Rosendo Augusto, Zanchin, Nilson Ivo Tonin, Brandalise, Sílvia Regina, Yunes, José Andrés |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537002/ |
Similar Items
-
Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice
by: Milani, Mateus, et al.
Published: (2015) -
Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice
by: Milani, Mateus, et al.
Published: (2015) -
SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1
by: de Vasconcellos, Jaíra Ferreira, et al.
Published: (2015) -
Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis
by: Silvia R. Brandalise, et al.
Published: (2017-06-01) -
Reconceptualizing synergism and antagonism among multiple stressors
by: Piggott, Jeremy J, et al.
Published: (2015)